Joshua Silverman's Net Worth
Estimate Recalculated Nov 1, 2024 09:49AM EST
Who is Joshua Silverman
Joshua Silverman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vringo Inc, Petros Pharmaceuticals, Inc., Akers Biosciences, Inc., Protagenic Therapeutics, Inc.\new, Synaptogenix, Inc., MGT CAPITAL INVESTMENTS INC, WPCS INTERNATIONAL INC, Neurotrope, Inc., TAPIMMUNE INC, PharmaCyte Biotech, Inc., ALANCO TECHNOLOGIES INC, NATIONAL HOLDINGS CORP, 24HOLDINGS INC, and FEMASYS INC.
SEC CIK
Joshua Silverman's CIK is 0001524858
Past Insider Trading and Trends
2020 was Joshua Silverman's most active year for acquiring shares with 21 total transactions. Joshua Silverman's most active month to acquire stocks was the month of November. 2020 was Joshua Silverman's most active year for disposing of shares, totalling 10 transactions. Joshua Silverman's most active month to dispose stocks was the month of November. 2021 saw Joshua Silverman paying a total of $186,357.66 for 983,906 shares, this is the most they've acquired in one year. In 2021 Joshua Silverman cashed out on 186,833 shares for a total of $391,012.46, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
